PMI Stock Analysis: Buy, Sell, or Hold?
PMI - Picard Medical, Inc.
$8.80
-0.29 (-3.19%)
▼
5d:
+174.14%
30d:
+7202.9%
90d:
+5403.44%
WAIT
LOW Confidence
Analysis Updated: Aug 28, 2026 12:00 AM ET
Earnings: Sep 10, 2026
11d
Get Alerted When PMI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: PMI is 34.4% above its trading range ($6.55). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: PMI is 34.4% above its trading range ($6.55). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: PMI is currently trading at $8.80, which is considered extended relative to its 30-day fair value range of $1.45 to $6.55.
Technical Outlook: Technically, PMI is in a uptrend. Immediate support is located at $2.65, while resistance sits at $11.13. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: PMI scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PMI is in a uptrend. Immediate support is located at $2.65, while resistance sits at $11.13. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: PMI scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.45 -
$6.55
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
0.0%
All Signals
- BEARISH: Price significantly overextended (+34.4% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.45 -
$6.55
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.65
Resistance Level
$11.13
Current Trend
Uptrend
Technical data as of
Aug 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.96
Revenue Growth (YoY)
38.6%
Share & Embed Analysis
Last updated: August 29, 2026 9:42 AM ET
Data refreshes hourly during market hours. Next update: 10:42 AM
Data refreshes hourly during market hours. Next update: 10:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PMI showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
NEUTRAL
Recent Transactions
Michael Patrick O'Shea
BUY
4463 shares
2026-04-24
Piers Godfrey Harrison
BUY
4463 shares
2026-04-24
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 48 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 56 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 67 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 43 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 43 HOLD |